As we explored in our other blog post, “Beyond the Pill Overview,” the pharmaceutical industry has begun huge shifts into a more customer-centric and outcome based focus and goal. It is no longer about just providing patients and customers with medications and pills to help treat their illnesses and ailments – it’s about helping patients achieve long-term health and improving overall wellbeing.
Patients expect their pharmaceutical companies to do more for them and to help in ways beyond just providing medications and pill to fix or help their ailments. With these shifts in our society, the pharmaceutical industry has no choice but to move into this new territory and adapt and evolve with our ever-growing world.
In order to achieve these large sweeping goals, the help of technology, IoT-based devices, Big Data, and the like, play a critical role in this transition. These elements are what will transition Pharma into to new world of ingestible tech pills, health-based wearables, and smartphone apps.
However, these kinds of systems are often challenging to develop and get just right – for both the company and the patient. Additionally, there are a host of other challenges to consider throughout this transition phase.
In this post, we will take a look at two of the most common challenges the pharmaceutical industry faces by going Beyond the Pill.
Since this is uncharted water, people placed in positions to lead these new efforts are generally people already within the company. These individuals typically do not have specific experience and training within this new technology centered and digital world. This makes creating and developing beyond the pill technologies and solutions challenging, if not completely impossible.